Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

ecancermedicalscience editor's choice for September 2015

Prof Gordon McVie - ecancer Managing Editor

ecancermedicalscience editor's choice for September 2015 ( Prof Gordon McVie - ecancer Managing Editor )

Results of a placebo controlled study of tasquinimod in men with metastatic...

Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA

Results of a placebo controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer ( Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA )

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden

ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )

Atezolizumab limits disease progression for metastatic urothelial bladder cancer

Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA

Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )

Multi-peptide vaccine for kidney cancer fails to improve survival

Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA

Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )

Prostate highlights from ECC 2015

Prof Noel Clarke and Dr Bertrand Tombal

Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Tailoring treatment strategies in prostate cancer: expert insight

Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu

Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )

Tackling global radiotherapy shortfall could save millions of lives and boost...

Prof Rifat Atun - Harvard University, Boston, USA

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

More from ecancer